Back
Storytel AB Vs. Corcept Therapeutics Industry Stock Comparison
Sell
46
STRYF
Storytel AB
Last Price:
5.17
Seasonality Move:
-14.83%
Buy
68
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Sell
46
Storytel AB (STRYF)
is a Sell
Is Storytel AB a Buy, Sell or Hold?
- The current Storytel AB [STRYF] share price is $5.17. The Score for STRYF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- STRYF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STRYF Stock Price Chart
What is Storytel AB's stock price today?
-
The Storytel AB share price today is $5.17
The current trend is relatively stagnant and STRYF is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $42.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
STRYF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 90.81 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.17 - 5.17) | Sell |
| Bollinger Bands (100): | (5.17 - 5.17) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.36 | Buy |
| Relative Strength Index (14 RSI): | 82.3 | Buy |
| Chaikin Money Flow: | 670376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.47 - 37.45) | Buy |
| Bollinger Bands (100): | (28.16 - 35.86) | Buy |
STRYF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.17 | Sell |
| 20-day SMA: | 5.17 | Sell |
| 50-day SMA: | 5.17 | Sell |
| 200-day SMA: | 4.39 | Buy |
| 8-day EMA: | 5.17 | Sell |
| 20-day EMA: | 5.17 | Buy |
| 50-day EMA: | 5.07 | Buy |
| 200-day EMA: | 8.36 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.44 | Buy |
| 20-day SMA: | 35.75 | Buy |
| 50-day SMA: | 34.88 | Buy |
| 200-day SMA: | 28.43 | Buy |
| 8-day EMA: | 38.24 | Buy |
| 20-day EMA: | 36.43 | Buy |
| 50-day EMA: | 34.68 | Buy |
| 200-day EMA: | 30.05 | Buy |
Storytel AB Earnings Growth & STRYF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
Storytel AB Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||